 Connection
Gabriella Hartman to Choroidal Neovascularization
This is a "connection" page, showing publications Gabriella Hartman has written about Choroidal Neovascularization.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.076 |
|
|
|
-
Hartman GD, Lambert-Cheatham NA, Kelley MR, Corson TW. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy. Int J Mol Sci. 2021 Sep 24; 22(19).
Score: 0.678
-
Muniyandi A, Hartman GD, Sishtla K, Rai R, Gomes C, Day K, Song Y, Masters AR, Quinney SK, Qi X, Woods H, Boulton ME, Meyer JS, Vilseck JZ, Georgiadis MM, Kelley MR, Corson TW. Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitor. Angiogenesis. 2025 Jan 05; 28(1):11.
Score: 0.213
-
Park B, Sardar Pasha SPB, Sishtla KL, Hartman GD, Qi X, Boulton ME, Corson TW. Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization. Int J Mol Sci. 2022 Dec 09; 23(24).
Score: 0.184
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|